| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/21/2011 | WO2011045340A1 Ido inhibitors and therapeutic uses thereof |
| 04/21/2011 | WO2011045257A1 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/21/2011 | WO2011045084A1 Quinolinyloxyphenylsulfonamides |
| 04/21/2011 | WO2011044978A1 Sulfoxide derivatives for treating tumors |
| 04/21/2011 | WO2011044824A1 Inclusion complex of deoxypodophyllotoxin of cyclodextrin, preparation method, use for treament of cancer thereof |
| 04/21/2011 | WO2011044721A1 Use of spink6 gene and protein encoded therein in the manufacture of anti-tumor medicaments |
| 04/21/2011 | WO2011044636A1 Na-k pump modulation |
| 04/21/2011 | WO2011026911A8 Bipyridines useful for the treatment of proliferative diseases |
| 04/21/2011 | WO2011012896A3 Spirocyclic amide derivatives |
| 04/21/2011 | WO2011009059A3 Method of treating or preventing cancer |
| 04/21/2011 | WO2011002184A3 Phosphoric acid ester of bicalutamide for treating prostate cancer |
| 04/21/2011 | WO2010148390A3 Polyamine transport inhibitors as novel therapeutics |
| 04/21/2011 | WO2010147971A3 Il23 modified viral vector for recombinant vaccines and tumor treatment |
| 04/21/2011 | WO2010141956A3 Methods and compositions for the treatment of cancer |
| 04/21/2011 | WO2010141842A3 Interlaced method for treating cancer or a precancerous condition |
| 04/21/2011 | WO2010141761A3 Polycyclic antagonists of lysophosphatidic acid receptors |
| 04/21/2011 | WO2010141406A3 Amino pyrimidine anticancer compounds |
| 04/21/2011 | WO2010141093A3 Co-signaling methods for treating cancers |
| 04/21/2011 | WO2010138803A3 Herv-k antigens, antibodies, and methods |
| 04/21/2011 | WO2010135662A3 Marker differentially expressed in cancer stem cells and methods of using same |
| 04/21/2011 | WO2010124283A4 Methods and compositions relating to hematologic malignancies |
| 04/21/2011 | WO2010002835A3 Vinpocetine and eburnamonine derivatives for promoting bone growth |
| 04/21/2011 | WO2008087558A3 Nucleoside and nucleotide analogues with quaternary carbon centers and methods of use |
| 04/21/2011 | US20110093962 Breast disease targets and uses thereof |
| 04/21/2011 | US20110092674 Non-Functional P2X7 Receptor |
| 04/21/2011 | US20110092603 Composition to enhance the bioavailability of curcumin |
| 04/21/2011 | US20110092601 Lysine-specific demethylase inhibitors |
| 04/21/2011 | US20110092595 Compositions and Methods for Treating Lung Cancer |
| 04/21/2011 | US20110092588 Lactone formulations and method of use |
| 04/21/2011 | US20110092586 Apoptosis inductor extracted from potato, potato foodstuff containing the inductor, and processed product thereof |
| 04/21/2011 | US20110092584 Therapeutic use of quinonoid derivatives of cannabinoids |
| 04/21/2011 | US20110092581 Docetaxel Formulations with Lipoic Acid |
| 04/21/2011 | US20110092576 Synthetic phosphodiester oligonucleotides and therapeutical uses thereof |
| 04/21/2011 | US20110092575 Sirna of human osteopontin |
| 04/21/2011 | US20110092572 Modulation of growth hormone receptor expression and insulin-like growth factor expression |
| 04/21/2011 | US20110092566 Treatment of cancer with aldose reductase inhibitors |
| 04/21/2011 | US20110092553 Substituted Azole Derivatives, Compositions, and Methods of Use |
| 04/21/2011 | US20110092548 Method for treating/preventing disease using cognitive ability of cerebrum and pharmaceutical |
| 04/21/2011 | US20110092546 Substituted benzimidazoles for neurofibromatosis |
| 04/21/2011 | US20110092545 Compounds, Compositions and Methods for Stabilizing Transthyretin and Inhibiting Transthyretin Misfolding |
| 04/21/2011 | US20110092538 Compounds and methods for kinase modulation, and indications therefor |
| 04/21/2011 | US20110092534 Ammosamides as Anticancer Agents |
| 04/21/2011 | US20110092530 Cyclopamine tartrate salt and uses thereof |
| 04/21/2011 | US20110092528 Piperidinyl compounds that selectively bind integrins |
| 04/21/2011 | US20110092527 4 (Pyrrolopyridinyl)pyrimidin-2-ylamine derivatives |
| 04/21/2011 | US20110092521 Methods of Treating Diseases Using Inhibitors of Nucleoside Phosphorylases and Nucleosidases |
| 04/21/2011 | US20110092520 Process for producing bicycloaniline derivatives |
| 04/21/2011 | US20110092514 Compounds with anti-cancer activity |
| 04/21/2011 | US20110092511 Inhibitors of akt activity |
| 04/21/2011 | US20110092508 Biomarkers of tumor pharmacodynamic response |
| 04/21/2011 | US20110092506 Trisubstituted amine compound |
| 04/21/2011 | US20110092505 Organic compounds |
| 04/21/2011 | US20110092504 Inhibitors of pi3 kinase |
| 04/21/2011 | US20110092503 Quinoline derivatives as axl kinase inhibitors |
| 04/21/2011 | US20110092502 Diaminothiazoles useful as axl inhibitors |
| 04/21/2011 | US20110092501 Novel inhibitors |
| 04/21/2011 | US20110092499 N-containing heterocyclic compounds |
| 04/21/2011 | US20110092498 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as met kinase inhibitors |
| 04/21/2011 | US20110092491 Compounds and Compositions as Inhibitors of Receptor Tyrosine Kinase Activity |
| 04/21/2011 | US20110092490 Pyrimidines, triazines and their use as pharmaceutical agents |
| 04/21/2011 | US20110092489 3-Aryl-Substituted Quinazolones, and Uses Thereof |
| 04/21/2011 | US20110092485 Substituted benzoazepines as toll-like receptor modulators |
| 04/21/2011 | US20110092482 Methods and compositions |
| 04/21/2011 | US20110092479 Pyrazole [3, 4-b] pyridine raf inhibitors |
| 04/21/2011 | US20110092477 Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines |
| 04/21/2011 | US20110092472 Enzymatic process for obtaining 17 alpha- monoesters of cortexolone and/or its 9,11- dehydroderivatives |
| 04/21/2011 | US20110092465 Monomeric pyrophosphate complexes and methods of treatment using the complexes |
| 04/21/2011 | US20110092461 Pyridyl inhibitors of hedgehog signalling |
| 04/21/2011 | US20110092459 Alpha helix mimetics and methods relating thereto |
| 04/21/2011 | US20110092452 Compositions and methods for diagnosing and treating pancreatic cancer |
| 04/21/2011 | US20110092451 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 04/21/2011 | US20110092447 Using inhibitors of histone deacetylases for the suppression therapy of inherited disease predisposing conditions |
| 04/21/2011 | US20110092442 Anticancer agent containing bl-angiostatin |
| 04/21/2011 | US20110092441 Cell-permeable endostatin recombinant protein, a polynucleotide encoding the same, and an anti-cancer preparation containing the same as an active component |
| 04/21/2011 | US20110092440 Method of regulating cell growth using a proteasome inhibitor |
| 04/21/2011 | US20110092437 Use of cyclic depsipeptides to inhibit kallikrein 7 |
| 04/21/2011 | US20110092428 Detecting and controlling abnormal hematopoiesis |
| 04/21/2011 | US20110092427 Polypeptide and pharmaceutical composition containing the polypeptide |
| 04/21/2011 | US20110092423 INHIBITORS OF Akt ACTIVITY |
| 04/21/2011 | US20110092412 Method of producing tat-hoxb4h |
| 04/21/2011 | US20110092411 Recombinant lactoferrins, methods of production from plants and uses thereof |
| 04/21/2011 | US20110091920 METHOD OF DIAGNOSING A CLINICAL CONDITION BY DETECTION OF A PAPP-A/proMBP COMPLEX |
| 04/21/2011 | US20110091892 Methods for the Diagnosis and Treatment of Lung Cancer |
| 04/21/2011 | US20110091876 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use |
| 04/21/2011 | US20110091574 Treatment of adenocarcinoma expressing lkb1 with mtor inhibitor in combination with cox2 inhibitor |
| 04/21/2011 | US20110091573 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| 04/21/2011 | US20110091567 Tissue organizing structure and therapeutic methods |
| 04/21/2011 | US20110091562 Nanogels for cellular delivery of therapeutics |
| 04/21/2011 | US20110091560 Compositions of nanoparticles and methods of making the same |
| 04/21/2011 | US20110091543 Oral delivery of modified transferrin fusion proteins |
| 04/21/2011 | US20110091539 Micronized Tanaproget and Compositions Containing Same |
| 04/21/2011 | US20110091534 Compositions comprising polymeric micelles for drug delivery |
| 04/21/2011 | US20110091529 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091528 Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms |
| 04/21/2011 | US20110091525 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 04/21/2011 | US20110091524 Biomarkers for sensitivity to anti-igf1r therapy |
| 04/21/2011 | US20110091523 Cochleate compositions directed against expression of proteins |
| 04/21/2011 | US20110091508 Oligofluorinated cross-linked polymers and uses thereof |
| 04/21/2011 | US20110091498 Methods of stimulating an immune response against prostate specific antigen |
| 04/21/2011 | US20110091489 Survivin peptide vaccine |